Enfermedad renal crónica y enfermedad arterial coronaria. Revisión de actualización de JACC
Mark J. Sarnaka,r, Kerstin Amannb,r, Sripal Bangalorec,r, João L. Cavalcanted,r, David M. Charytane,r, Jonathan C. Craigf,r, John S. Gillg,r, Mark A. Hlatkyh,r, Alan G. Jardinei,r, Ulf Landmesserj,r, L. Kristin Newbyk,r, Charles A. Herzogl,m,r, Michael Cheungn,r, David C. Wheelero,r, Wolfgang C. Winkelmayerp,r, Thomas H. Marwickq,r
a Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, Estados Unidos.
b Department of Nephropathology, University Hospital Erlangen, Erlangen, Alemania.
c Division of Cardiology, New York University School of Medicine, Nueva York, Nueva York, Estados Unidos.
d Minneapolis Heart Institute, Minneapolis, Minnesota, Estados Unidos.
e Division of Nephrology, New York University School of Medicine, Nueva York, Nueva York, Estados Unidos.
f College of Medicine and Public Health, Flinders University, Adelaida, South Australia, Australia.
g Division of Nephrology, St. Paul´s Hospital, University of British Columbia, Vancouver, British Columbia, Canadá.
h Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, Estados Unidos.
i Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Reino Unido.
j Department of Cardiology, Charité Universitätsmedizin, Berlín, Alemania.
k Division of Cardiology, Department of Medicine and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, Estados Unidos.
l Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota, Estados Unidos.
m Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, Estados Unidos.
n Kidney Disease: Improving Global Outcomes, Bruselas, Bélgica.
o University College London, Londres, Reino Unido.
p Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, Estados Unidos.
q Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
r En nombre de los participantes en la conferencia
